Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
749,239
-
Share change
-
-74,702
-
Total reported value
-
$114,979,884
-
Put/Call ratio
-
233%
-
Price per share
-
$153.28
-
Number of holders
-
97
-
Value change
-
-$11,533,621
-
Number of buys
-
24
-
Number of sells
-
41
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2025
As of 30 Jun 2025,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
749,239 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Miller Investment Management, LP, RAYMOND JAMES FINANCIAL INC, TD Waterhouse Canada Inc., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, LPL Financial LLC, UBS Group AG, and Royal Bank of Canada.
This page lists
97
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.